Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | EYA2 | O00167 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | DRD1 | P21728 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | DRD3 | P35462 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12581441 | 0.85 | MEN1 (0.32) | KMT2A | |
| SCHEMBL260576 | 0.85 | MEN1 (0.32) | KMT2A | |
| SCHEMBL12347474 | 0.85 | MEN1 (0.32) | KMT2A | |
| SCHEMBL16297673 | 0.84 | ALDH1A1 (0.37) | FFAR3TDP1LMNATSHRALOX15 | |
| SCHEMBL8045363 | 0.83 | ALDH1A1 (0.36) | TDP1 | |
| SCHEMBL5080836 | 0.83 | CA12 (0.43) | FFAR3TDP1EYA2APPACE | |
| SCHEMBL6444629 | 0.82 | FFAR3 (0.47) | FFAR3TDP1EYA2APPACE | |
| SCHEMBL8602002 | 0.80 | FFAR3 (0.45) | FFAR3TDP1EYA2APPACE | |
| SCHEMBL12933034 | 0.79 | TDP1 (0.36) | TDP1EYA2APPACELMNA | |
| SCHEMBL24312108 | 0.79 | CACNA2D1 (0.36) | TDP1EYA2APPACELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170309842-A1 | SELF-ASSEMBLED PEPTIDE NUCLEIC ACIDS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-10-26 | — | — | US | disclosed |
| US-9741948-B2 | Self-assembled peptide nucleic acids | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-22 | — | — | US | disclosed |
| US-20160164010-A1 | SELF-ASSEMBLED PEPTIDE NUCLEIC ACIDS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2016-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164010-A1 | SELF-ASSEMBLED PEPTIDE NUCLEIC ACIDS | RNGTT, CGAS, SARNP | FFAR3 3460/4885TDP1 78/4885EYA2 1080/4885 |
| US-20170309842-A1 | SELF-ASSEMBLED PEPTIDE NUCLEIC ACIDS | RNGTT, CGAS, SARNP | FFAR3 3460/4885TDP1 78/4885EYA2 1080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.